Moore Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-325,000	Closed	-$19.3M	–	666
2025 Q4	$19.3M	Buy	+325,000	New	+$17.7M	0.39%	95
2024 Q3	–	Sell	-250,000	Closed	-$20.6M	–	472
2024 Q2	$20.6M	Sell	250,000 -10,000	-4%	-$833K	0.45%	86
2024 Q1	$22.7M	Buy	260,000 +50,000	+24%	+$4.48M	0.47%	66
2023 Q4	$20.2M	Buy	210,000 +14,800	+8%	+$1.31M	0.49%	53
2023 Q3	$17.3M	Buy	195,200 +35,200	+22%	+$3.13M	0.47%	60
2023 Q2	$13.9M	Buy	160,000 +130,000	+433%	+$12.2M	0.34%	78
2023 Q1	$2.92M	Sell	30,000 -100,000	-77%	-$10.4M	0.09%	210
2022 Q4	$13.5M	Buy	130,000 +76,012	+141%	+$7.14M	0.38%	49
2022 Q3	$4.58M	Sell	53,988 -20,576	-28%	-$1.83M	0.13%	209
2022 Q2	$6.18M	Buy	74,564 +17,207	+30%	+$1.37M	0.19%	139
2022 Q1	$4.42M	Sell	57,357 -114,714	-67%	-$9.6M	0.15%	224
2021 Q4	$15.2M	Buy	+172,071	New	+$14.2M	0.38%	63
2016 Q1	–	Sell	-122,000	Closed	-$12.8M	–	249
2015 Q4	$12.8M	Buy	+122,000	New	+$12.7M	0.45%	72
2015 Q2	–	Sell	-27,500	Closed	-$3.43M	–	429
2015 Q1	$3.43M	Sell	27,500 -28,600	-51%	-$3.03M	0.12%	215
2014 Q4	$5.07M	Buy	+56,100	New	+$4.67M	0.22%	137
2013 Q4	–	Sell	-62,500	Closed	-$4.51M	–	377
2013 Q3	$4.51M	Buy	+62,500	New	+$4.15M	0.18%	167